Division of Neurology and Clinical Neuroscience, Department of Internal Medicine III, Yamagata University School of Medicine, Yamagata, Japan.
Department of Psychiatry, Kochi Medical School, Kochi University, Kochi, Japan.
J Neurol Sci. 2020 Dec 15;419:117166. doi: 10.1016/j.jns.2020.117166. Epub 2020 Oct 3.
Our previous community-based study demonstrated that some individuals with AVIM [asymptomatic ventriculomegaly with features of idiopathic normal pressure hydrocephalus (iNPH) on magnetic resonance imaging (MRI)] progressed to iNPH in several years. In this hospital-based study, we investigated the progression rate from AVIM to iNPH and its possible predictors.
We conducted a prospective study of participants with AVIM from several medical institutions/hospitals in Japan. AVIM is defined as "asymptomatic ventriculomegaly with features of iNPH on MRI"; in the present study, asymptomatic was defined as "0 (no symptoms) or 1 (presence of only subjective, but not objective, symptoms) on the iNPH Grading Scale (iNPH-GS)." We also measured possible predicting factors for AVIM-to-iNPH progression, including age, sex, body weight, blood pressure, diabetes mellitus, dyslipidemia, history of mental disease/head injury/sinusitis/smoking/alcohol-intake, Evans index, and the presence of DESH (disproportionately enlarged subarachnoid-space hydrocephalus) findings on brain MRI, and analyzed these potential predictive values.
In 2012, 93 participants with AVIM were registered and enrolled in the study. Of these, 52 participants were able to be tracked for three years (until 2015). Of the 52 participants, 27 (52%) developed iNPH during the follow-up period (11 definite, 6 probable, and 10 possible iNPH), whereas 25 participants remained asymptomatic in 2015. Among the possible predictive factors examined, the baseline scores of iNPH-GS predicted the AVIM-to-iNPH progression.
The multicenter prospective study demonstrated that the progression rate from AVIM to iNPH was ~17% per year, and the baseline scores of iNPH-GS predicted the AVIM-to-iNPH progression.
我们之前的社区研究表明,一些磁共振成像(MRI)显示无症状脑室扩大伴特发性正常压力脑积水(iNPH)特征的患者(AVIM)在数年内进展为 iNPH。在这项基于医院的研究中,我们调查了从 AVIM 进展为 iNPH 的速度及其可能的预测因素。
我们对来自日本多家医疗机构/医院的 AVIM 患者进行了前瞻性研究。AVIM 定义为“MRI 显示无症状脑室扩大伴 iNPH 特征”;在本研究中,无症状定义为“iNPH 分级量表(iNPH-GS)为 0(无症状)或 1(仅存在主观但无客观症状)”。我们还测量了 AVIM 进展为 iNPH 的可能预测因素,包括年龄、性别、体重、血压、糖尿病、血脂异常、精神疾病/头部损伤/鼻窦炎/吸烟/饮酒史、Evans 指数以及脑 MRI 上是否存在 DESH(蛛网膜下腔不成比例扩大性脑积水)发现,并分析了这些潜在预测值。
2012 年,93 名 AVIM 患者登记并参加了该研究。其中,52 名患者可追踪 3 年(直到 2015 年)。在 52 名参与者中,27 名(52%)在随访期间出现 iNPH(11 例确诊,6 例可能,10 例可疑),而 25 名参与者在 2015 年仍无症状。在检查的可能预测因素中,基线 iNPH-GS 评分预测了 AVIM 向 iNPH 的进展。
多中心前瞻性研究表明,从 AVIM 进展为 iNPH 的速度约为每年 17%,基线 iNPH-GS 评分预测了 AVIM 向 iNPH 的进展。